Skip to main content

Moderna Inc. Archives

VUMC-led study finds Moderna COVID vaccine safe and effective for children

May. 12, 2022—  by Bill Snyder Moderna’s COVID-19 vaccine is safe and generates robust immune responses in children ages 6 to 11 years, a national clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found. The two-dose vaccine (given approximately one month apart) led to antibody responses in more than...

Read more


Volunteering for vaccine research a family affair

Apr. 13, 2022—by Kristin Smart The Disney dream was deferred. Jennifer Andrews, her husband Chris Murdock, and their 6-year-old daughter Ella were all packed for a trip to Disney World in early March 2020, when they joined much of the world in having their plans upended by the COVID-19 pandemic. “We were supposed to leave on March...

Read more


Vanderbilt recruiting children to study allergic responses to COVID-19 mRNA vaccines

Jan. 24, 2022—Vanderbilt is conducting a clinical trial to determine risk and mechanisms of allergic reactions to COVID-19 Pfizer-BioNTech mRNA vaccine among children.

Read more


VUMC researchers involved in developing Moderna’s COVID-19 vaccine featured in Smithsonian exhibit

Nov. 23, 2021—Researchers at Vanderbilt University Medical Center who contributed to the development of Moderna’s COVID-19 vaccine are featured in a new exhibit at the Smithsonian Institution in Washington, D.C.

Read more


Monroe Carell Jr. Children’s Hospital at Vanderbilt selected as trial site for pediatric COVID-19 vaccine

Mar. 30, 2021—Monroe Carell Jr. Children’s Hospital at Vanderbilt is set to begin a phase 2/3 clinical trial to study the safety and efficacy of the Moderna COVID-19 vaccine in children.

Read more


HHS Secretary Azar visits VUMC

Sep. 17, 2020—U.S. Health and Human Services Secretary Alex Azar visited VUMC Tuesday, Sept. 15, to learn more about the Medical Center’s ongoing Moderna COVID-19 vaccine trial and the convalescent plasma trial.

Read more


Vanderbilt University Medical Center to recruit up to 1,000 volunteers for COVID-19 vaccine Trial

Jul. 15, 2020—In late July, Vanderbilt University Medical Center will begin recruiting up to 1,000 volunteers in a late-stage study of an experimental COVID-19 vaccine developed by Moderna Inc. in collaboration with the Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Read more


VUMC studies provide key positive results for COVID-19 vaccine in early-stage clinical trial

Jul. 14, 2020—An experimental coronavirus vaccine stimulated robust immune responses against SARS-CoV-2, the virus that causes COVID-19, and raised no serious safety concerns in an early-stage clinical trial.

Read more


Early effort to thwart chikungunya infection shows positive results

Sep. 13, 2019—Phase 1 trial results in new approach to combat the chikungunya

Read more


New method tested to block chikungunya infection

Jun. 14, 2019—Scientists are testing a new way to fight chikungunya virus that involves injecting genetic material into the bodies of infected and at-risk individuals to trigger rapid production of potent, virus-neutralizing antibodies.

Read more


VUMC chikungunya antibody set to enter clinical trial

Feb. 21, 2019—A monoclonal antibody against the chikungunya virus developed by researchers at Vanderbilt University Medical Center is the first monoclonal antibody encoded by messenger RNA to enter a clinical trial.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more